The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Schlorff Eric | Chief Executive Officer | Grant(A) | 30K | — | $0 |
| Feb 6, 2026 | Chung Kevin | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Feb 6, 2026 | Towne Bradford K | Principal Accounting Officer | Grant(A) | 8K | — | $0 |
| Feb 6, 2026 | Baird Jennifer A | Director | Grant(A) | 3K | — | $0 |
| Feb 6, 2026 | Vincent Bernadette N | Director | Grant(A) | 3K | — | $0 |
| Feb 6, 2026 | Neuman John | Director | Grant(A) | 3K | — | $0 |
| Feb 6, 2026 | Van Heel Kenneth | Director | Grant(A) | 3K | — | $0 |
| Dec 19, 2025 | Baird Jennifer A | Director | Buy(P) | 4K | $0.24 | $1K |
| Dec 9, 2025 | Messinger Michael | Chief Financial Officer | Buy(P) | 15K | $0.35 | $5K |
| Aug 27, 2025 | Van Heel Kenneth | Director | Buy(P) | 10K | $0.86 | $9K |
| Aug 26, 2025 | Van Heel Kenneth | Director | Buy(P) | 25K | $0.89 | $22K |
| Aug 22, 2025 | Chung Kevin | Chief Medical Officer | Buy(P) | 10K | $0.80 | $8K |
| Jul 10, 2025 | Van Heel Kenneth | Director | Grant(A) | 4K | — | $0 |
| Jul 10, 2025 | Vincent Bernadette N | Director | Grant(A) | 4K | — | $0 |
| Jul 10, 2025 | Neuman John | Director | Grant(A) | 4K | — | $0 |
| Jul 10, 2025 | Baird Jennifer A | Director | Grant(A) | 4K | — | $0 |
| Jul 1, 2025 | Schlorff Eric | Chief Executive Officer, Director | Option exercise(M) | 22K | — | $0 |
| Jul 1, 2025 | Schlorff Eric | Chief Executive Officer, Director | Option exercise(M) | 22K | — | $0 |
| Jul 1, 2025 | Chung Kevin | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jul 1, 2025 | Chung Kevin | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jun 30, 2025 | Baird Jennifer A | Director | Buy(P) | 10K | $0.42 | $4K |
| Jun 24, 2025 | Neuman John | Director | Buy(P) | 40K | $0.36 | $14K |
| Jun 4, 2025 | Baird Jennifer A | Director | Option exercise(M) | 3K | — | $0 |
| Jun 4, 2025 | Baird Jennifer A | Director | Option exercise(M) | 3K | — | $0 |
| Jun 4, 2025 | Van Heel Kenneth | Director | Option exercise(M) | 4K | — | $0 |
| Jun 4, 2025 | Van Heel Kenneth | Director | Option exercise(M) | 4K | — | $0 |
| Jun 4, 2025 | Vincent Bernadette N | Director | Option exercise(M) | 3K | — | $0 |
| Jun 4, 2025 | Vincent Bernadette N | Director | Option exercise(M) | 3K | — | $0 |
| Jun 4, 2025 | Neuman John | Director | Option exercise(M) | 3K | — | $0 |
| Jun 4, 2025 | Neuman John | Director | Option exercise(M) | 3K | — | $0 |
| May 20, 2025 | Chung Kevin | Chief Medical Officer | Buy(P) | 5K | $1.25 | $6K |
| May 20, 2025 | Baird Jennifer A | Director | Buy(P) | 10K | $1.28 | $13K |
| Apr 1, 2025 | Green David A | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Apr 1, 2025 | Chung Kevin | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Dec 11, 2024 | Neuman John | Director | Buy(P) | 10K | $2.04 | $20K |
| Nov 18, 2024 | Chung Kevin | Chief Medical Officer | Buy(P) | 4K | $1.99 | $8K |
| Nov 15, 2024 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 65K | — | $0 |
| Nov 15, 2024 | Chung Kevin | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Nov 13, 2024 | Collins Allan | Director | Grant(A) | 4K | — | $0 |
| Nov 13, 2024 | Neuman John | Director | Grant(A) | 8K | — | $0 |
| Nov 13, 2024 | Van Heel Kenneth | Director | Grant(A) | 4K | — | $0 |
| Nov 13, 2024 | Barnett Rick | Director | Grant(A) | 4K | — | $0 |
| Nov 13, 2024 | Vincent Bernadette N | Director | Grant(A) | 8K | — | $0 |
| Nov 13, 2024 | Baird Jennifer A | Director | Grant(A) | 8K | — | $0 |
| Sep 30, 2024 | Chung Kevin | Chief Medical Officer | Buy(P) | 1K | $4.26 | $4K |
| Aug 30, 2024 | Green David A | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Aug 15, 2024 | Neuman John | Director | Buy(P) | 10K | $5.24 | $52K |
| Jun 17, 2024 | Neuman John | Director | Buy(P) | 10K | $4.35 | $44K |
| Jun 14, 2024 | Neuman John | Director | Buy(P) | 10K | $3.69 | $37K |
| Apr 18, 2024 | Green David A | Chief Financial Officer | Grant(A) | 2K | — | $0 |
| Apr 12, 2024 | Green David A | Chief Financial Officer | Grant(A) | 18K | — | $0 |
| Apr 12, 2024 | Rodgers Bruce M. | Director | Grant(A) | 37K | — | $0 |
| Apr 12, 2024 | Collins Allan | Director | Grant(A) | 38K | — | $0 |
| Apr 12, 2024 | Van Heel Kenneth | Director | Grant(A) | 44K | — | $0 |
| Apr 12, 2024 | Barnett Rick | Director | Grant(A) | 70K | — | $0 |
| Apr 12, 2024 | Lobo Andres | Director | Grant(A) | 32K | — | $0 |
| Apr 12, 2024 | Russell Richard D. | Director | Grant(A) | 32K | — | $0 |
| Apr 12, 2024 | Green David A | Chief Financial Officer | Grant(A) | 753K | — | $0 |
| Nov 29, 2023 | Baron Caryl | Interim CFO | Grant(A) | 20K | — | $0 |
| Nov 29, 2023 | Chung Kevin | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Nov 29, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 60K | — | $0 |
| Nov 22, 2023 | Van Heel Kenneth | Director | Buy(P) | 100K | $0.40 | $40K |
| Sep 22, 2023 | Baron Caryl | Interim CFO | Other(J) | 15K | — | $0 |
| Sep 15, 2023 | Baron Caryl | Interim CFO | Grant(A) | 4K | — | $0 |
| Sep 15, 2023 | Chung Kevin | Chief Medical Officer | Grant(A) | 34K | — | $0 |
| Sep 15, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 41K | — | $0 |
| Aug 31, 2023 | Baron Caryl | Interim CFO | Grant(A) | 3K | — | $0 |
| Aug 31, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 34K | — | $0 |
| Aug 31, 2023 | Chung Kevin | Chief Medical Officer | Grant(A) | 28K | — | $0 |
| Aug 15, 2023 | Chung Kevin | Chief Medical Officer | Grant(A) | 17K | — | $0 |
| Aug 15, 2023 | Baron Caryl | Interim CFO | Grant(A) | 2K | — | $0 |
| Aug 15, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 417K | — | $0 |
| Jun 9, 2023 | Baron Caryl | Interim CFO | Grant(A) | 57K | — | $0 |
| Jun 9, 2023 | Baron Caryl | Interim CFO | Tax withholding(F) | 15K | $0.53 | $8K |
| May 30, 2023 | Chung Kevin | Chief Medical Officer | Buy(P) | 1K | $0.48 | $552 |
| May 30, 2023 | Chung Kevin | Chief Medical Officer | Buy(P) | 2K | $0.48 | $1K |
| May 30, 2023 | Chung Kevin | Chief Medical Officer | Buy(P) | 4K | $0.48 | $2K |
| May 30, 2023 | Chung Kevin | Chief Medical Officer | Buy(P) | 5K | $0.47 | $2K |
| May 25, 2023 | Russell Richard D. | Director | Buy(P) | 20K | $0.50 | $10K |
| May 18, 2023 | Chung Kevin | Chief Medical Officer | Buy(P) | 8K | $0.70 | $5K |
| Apr 6, 2023 | Rodgers Bruce M. | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Rodgers Bruce M. | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Baron Caryl | Interim CFO | Grant(A) | 17K | — | $0 |
| Apr 6, 2023 | Baron Caryl | Interim CFO | Grant(A) | 11K | — | $0 |
| Apr 6, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 100K | — | $0 |
| Apr 6, 2023 | Schlorff Eric | Chief Executive Officer, Director | Grant(A) | 66K | — | $0 |
| Apr 6, 2023 | Collins Allan | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Collins Allan | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Van Heel Kenneth | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Van Heel Kenneth | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Barnett Rick | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Barnett Rick | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Lobo Andres | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Lobo Andres | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Russell Richard D. | Director | Grant(A) | 12K | — | $0 |
| Apr 6, 2023 | Russell Richard D. | Director | Grant(A) | 8K | — | $0 |
| Apr 6, 2023 | Chung Kevin | Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Apr 6, 2022 | Chung Kevin | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Apr 5, 2022 | Chung Kevin | Chief Medical Officer | Buy(P) | 4K | $1.85 | $7K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).